Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.

Cacicedo J, Navarro A, Del Hoyo O, Gomez-Iturriaga A, Alongi F, Medina JA, Elicin O, Skanjeti A, Giammarile F, Bilbao P, Casquero F, de Bari B, Dal Pra A.

Br J Radiol. 2016 Nov;89(1067):20160217. Epub 2016 Aug 2. Review.

PMID:
27416996
2.

Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers.

Siddiqui F, Yao M.

World J Radiol. 2014 Jun 28;6(6):238-51. doi: 10.4329/wjr.v6.i6.238. Review.

3.

Long-term surgical complications in the oral cancer patient: a comprehensive review. Part I.

Kolokythas A.

J Oral Maxillofac Res. 2010 Oct 1;1(3):e1. doi: 10.5037/jomr.2010.1301. eCollection 2010.

4.

FDG-PET, a Complementary Modality to Computed-Tomography in Radiotherapy Target Volume Delineation for Head and Neck Cancer.

Bar-Ad V, Shi W, Tuluc M, Ohri N, Cognetti D, Curry J, Intenso C.

J Nucl Med Radiat Ther. 2012 Feb 1;3(1). doi: 10.4172/2155-9619.1000124.

5.

Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.

Mason NS, Lopresti BJ, Ruszkiewicz J, Dong X, Joyce S, Leef G, Sen M, Wahed AS, Mathis CA, Grandis JR, Thomas SM.

Am J Nucl Med Mol Imaging. 2013;3(1):16-31. Epub 2013 Jan 5.

6.

Metastatic parotid myoepithelial carcinoma in a 7-year-old boy.

Saliba I, El Khatib N, Nehme A, Nasser S, Moukarzel N.

Case Rep Pediatr. 2012;2012:212746. Epub 2012 Sep 13.

7.

Newer imaging techniques in head and neck cancer.

Purandare NC, Rangarajan V.

Indian J Surg Oncol. 2010 Apr;1(2):186-93. doi: 10.1007/s13193-010-0031-9. Epub 2010 Nov 21.

8.

Glucose deprivation-induced metabolic oxidative stress and cancer therapy.

Simons AL, Mattson DM, Dornfeld K, Spitz DR.

J Cancer Res Ther. 2009 Sep;5 Suppl 1:S2-6. doi: 10.4103/0973-1482.55133. Review.

9.

Diffusion-weighted imaging in head and neck cancers.

Chawla S, Kim S, Wang S, Poptani H.

Future Oncol. 2009 Sep;5(7):959-75. doi: 10.2217/fon.09.77. Review.

10.

Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.

Al-Ibraheem A, Buck A, Krause BJ, Scheidhauer K, Schwaiger M.

J Oncol. 2009;2009:208725. doi: 10.1155/2009/208725. Epub 2009 Aug 20.

12.

Enhanced response of human head and neck cancer xenograft tumors to cisplatin combined with 2-deoxy-D-glucose correlates with increased 18F-FDG uptake as determined by PET imaging.

Simons AL, Fath MA, Mattson DM, Smith BJ, Walsh SA, Graham MM, Hichwa RD, Buatti JM, Dornfeld K, Spitz DR.

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1222-30.

Supplemental Content

Support Center